{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T06:39:02Z","timestamp":1792391942783,"version":"4.4.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Continuum"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1212\/01.con.0000429170.50686.4e","type":"journal-article","created":{"date-parts":[[2016,4,20]],"date-time":"2016-04-20T15:52:16Z","timestamp":1461167536000},"page":"475-479","source":"Crossref","is-referenced-by-count":4,"title":["Genetic Testing for Early-Onset Alzheimer Disease"],"prefix":"10.1212","volume":"19","author":[{"given":"Jack W.","family":"Tsao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_4_2","doi-asserted-by":"crossref","unstructured":"Alonso Vilatela ME L\u00f3pez L\u00f3pez M Yescas G\u00f3mez P. Genetics of Alzheimer\u2019s disease. Arch Med Res 2012; PII:S0188-4409(12)00299-8.","DOI":"10.1016\/j.arcmed.2012.10.017"},{"key":"e_1_3_1_5_2","doi-asserted-by":"crossref","unstructured":"Sherrington R Froelich S Sorbi S et al.. Alzheimer\u2019s disease associated with mutations in presenilin 2 is rare and variably penetrant. Hum Mol Genet 1996; 5 (7): 985\u2013988.","DOI":"10.1093\/hmg\/5.7.985"},{"key":"e_1_3_1_6_2","unstructured":"Tanzi RE Vaula G Romano DM et al.. Assessment of amyloid beta-protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases. Am J Hum Genet 1992; 51 (2): 273\u2013282."},{"key":"e_1_3_1_8_2","doi-asserted-by":"crossref","unstructured":"Burgunder JM Finsterer J Szolnoki Z et al.. EFNS guidelines on the molecular diagnosis of channelopathies epilepsies migraine stroke and dementias. Eur J Neurol 2010; 17 (5): 641\u2013648.","DOI":"10.1111\/j.1468-1331.2010.02985.x"},{"key":"e_1_3_1_9_2","doi-asserted-by":"crossref","unstructured":"Goldman JS Hahn SE Catania JW et al.. Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genet Med 2011; 13 (6): 597\u2013605.","DOI":"10.1097\/GIM.0b013e31821d69b8"},{"key":"e_1_3_1_10_2","unstructured":"Mayeux R Saunders AM Shea S et al.. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer\u2019s disease. Alzheimer\u2019s Disease Centers Consortium on Apolipoprotein E and Alzheimer\u2019s Disease. N Engl J Med 1998; 338 (8): 506\u2013511."},{"key":"e_1_3_1_11_2","doi-asserted-by":"crossref","unstructured":"Roberts JS LaRusse SA Katzen H et al.. Reasons for seeking genetic susceptibility testing among first-degree relatives for people with Alzheimer disease. Alzheimer Dis Assoc Disord 2003; 17 (2): 86\u201393.","DOI":"10.1097\/00002093-200304000-00006"},{"key":"e_1_3_1_12_2","doi-asserted-by":"crossref","unstructured":"Neumann PJ Hammitt JK Mueller C et al.. Public attitudes about genetic testing for Alzheimer\u2019s disease. Health Aff (Millwood) 2001; 20 (5): 252\u2013264.","DOI":"10.1377\/hlthaff.20.5.252"},{"key":"e_1_3_1_14_2","doi-asserted-by":"crossref","unstructured":"Zick CD Mathews CJ Roberts S et al.. Genetic testing for Alzheimer\u2019s disease and its impact on insurance purchasing behavior. Health Aff (Millwood) 2005; 24 (2): 483\u2013490.","DOI":"10.1377\/hlthaff.24.2.483"},{"key":"e_1_3_1_15_2","unstructured":"MetLife Foundation. MetLife Foundation Alzheimer\u2019s survey: what America thinks. New York NY: MetLife Foundation 2006."},{"key":"e_1_3_1_16_2","doi-asserted-by":"crossref","unstructured":"Cassidy MR Roberts JS Bird TD et al.. Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer\u2019s disease. Alzheimers Dement 2008; 4 (6): 406\u2013413.","DOI":"10.1016\/j.jalz.2008.04.007"},{"key":"e_1_3_1_17_2","doi-asserted-by":"crossref","unstructured":"Green RC Roberts JS Cupples LA et al.. Disclosure of APOE genotype for risk of Alzheimer\u2019s disease. N Engl J Med 2009; 361 (3): 245\u2013254.","DOI":"10.1056\/NEJMoa0809578"}],"container-title":["Continuum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1212\/01.CON.0000429170.50686.4e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T13:59:36Z","timestamp":1752155976000},"score":1,"resource":{"primary":{"URL":"https:\/\/continuum.aan.com\/doi\/10.1212\/01.CON.0000429170.50686.4e"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["10.1212\/01.CON.0000429170.50686.4e"],"URL":"https:\/\/doi.org\/10.1212\/01.con.0000429170.50686.4e","relation":{},"ISSN":["1080-2371","1538-6899"],"issn-type":[{"value":"1080-2371","type":"print"},{"value":"1538-6899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}